Similar companies
Income Statement (USD)
| Q4 '24 | QoQ | |
|---|---|---|
| Operating expense | 30M | 11.6% |
| Net Income | -29M | 10.6% |
| EBITDA | -30M | 11.9% |
Balance Sheet (USD)
| Q4 '24 | QoQ | |
|---|---|---|
| Total Assets | 80M | 27.6% |
| Total Liabilities | 28M | 17.7% |
| Total Equity | 52M | 32.1% |
| Shares Outstanding | 36M | 0.1% |
Cash Flow (USD)
| Q4 '24 | QoQ | |
|---|---|---|
| Cash from operations | -30M | 19% |
| Cash from financing | 410,000 | 498.6% |
EPS
Financial Highlights for Biomea Fusion in Q4 '24
Operating Expenses for this period were 30M, showing a -11.6% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -29M, showing a 10.6% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -30M, showing a 11.9% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
The company's performance remained stable this quarter with no significant positive or negative changes in the key financial metrics.
